Opendata, web and dolomites


Feasibility assessment of a cloud application platform for rational drug design using high throughput molecular dynamics

Total Cost €


EC-Contrib. €






 HTMD project word cloud

Explore the words cloud of the HTMD project. It provides you a very rough idea of what is the project "HTMD" about.

platform    degree    interfaces    unnecessary    barrier    throughput    environment    inform    cloud    1000m    biological    acellera    simulations    larger    market    reduce    prototyping    feasibility    competitiveness    interactions    spending    clinical    description    instrument    gain    pace    invest    global    htmd    drugs    leader    ready    resolution    complexity    companies    virtualizing    translating    entry    identification    viability    pcr    optimized    traction    speed    simulation    interact    proposes    substantially    positioned    workflows    resource    computational    trl    accurate    pharmaceutical    productivity    combines    looks    launch    approximately    unprecedented    preparations    proposing    accuracy    computationally    subsequent    significantly    approved    drug    discovery    solution    limits    candidate    progress    expensive    silico    demonstration    molecular    uniquely    proprietary    md    sme    beginning    industry    provides    dynamics    rational    disruptive   

Project "HTMD" data sheet

The following table provides information about the project.


Organization address
address: C/ DELS PINZON 19 2-4
postcode: 8003
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-06-01   to  2015-11-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ACELLERA LABS SL ES (BARCELONA) coordinator 50˙000.00


 Project objective

The pharmaceutical industry’s increasing spending on R&D is not translating into new and better drugs at the pace required to maintain competitiveness. In-silico computational methods are beginning to gain traction in the progress towards more rational drug discovery workflows. Among the methods available, molecular dynamics (MD) provides the most accurate and useful description of molecular interactions, but the current state of the art has both a high degree of unnecessary technical complexity, and is computationally expensive. Together, these two factors have produced a high barrier to entry that substantially limits research productivity.Acellera looks to address these issues by proposing a cloud application platform for high-throughput MD (HTMD) simulations. This computational platform combines proprietary simulation technology - optimized for speed and simulation throughput – and user-friendly interfaces in a cloud environment to provide a novel resource for drug candidate identification. HTMD, which allows understanding with an unprecedented degree of resolution and accuracy how drugs interact with their biological targets, can significantly reduce the cost of pre-clinical research (PCR) by virtualizing key steps. It is currently estimated that pharmaceutical companies invest approximately 1000M Euro per approved drug. As a global leader in the development of technology for high-throughput molecular dynamics, Acellera is uniquely positioned to bring this disruptive computational technology to the market. The HTMD platform is ready for prototyping in an operational environment (TRL 6). Acellera proposes a Phase 1 SME Instrument to support the execution of a feasibility study into the market viability of the HTMD solution for pre-clinical research. Results of the study will be used to inform preparations for a larger-scale demonstration in Phase 2 and for the subsequent market launch.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HTMD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HTMD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Starcounter (2017)

In-Memory Computing and Artificial Intelligence Platform for Building Next Generation Enterprise Software

Read More  

oWBI (2018)

Osmotic Wearable Bolus Injector (oWBI) for viscous drug delivery

Read More  

scanvid (2017)

ScanVid - One-Click Integrated Access to Product-related Digital Content

Read More